Engineering of primary carbon metabolism for improved antibiotic production in Streptomyces lividans

被引:63
作者
Butler, MJ
Bruheim, P
Jovetic, S
Marinelli, F
Postma, PW
Bibb, MJ
机构
[1] John Innes Ctr, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England
[2] Norwegian Univ Sci & Technol, Dept Biotechnol, N-7491 Trondheim, Norway
[3] Biosearch Italia SpA, I-21040 Gerenzano, VA, Italy
[4] Univ Amsterdam, EC Slater Inst Biochem Res, Fac Chem, NL-1018 WS Amsterdam, Netherlands
关键词
D O I
10.1128/AEM.68.10.4731-4739.2002
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Deletions were made in Streptomyces lividans in either of two genes (zwf1 and zwf2) encoding isozymes of glucose-6-phosphate dehydrogenase, the first enzyme in the oxidative pentose phosphate pathway (PPP). Each mutation reduced the level of Zwf activity to approximately one-half that observed in the wild-type strain. When the mutants were transformed with multicopy plasmids carrying the pathway-specific transcriptional activator genes for either the actinorhodin (ACT) or undecylprodigiosin (RED) biosynthetic pathway, they produced higher levels of antibiotic than the corresponding wild-type control strains. The presumed lower flux of carbon through the PPP in each of the Deltazwf mutants may allow more efficient glucose utilization via glycolysis, resulting in higher levels of antibiotic production. This appears to occur without lowering the concentration of NADPH (the major biochemical product of the oxidative PPP activity) to a level that would limit antibiotic biosynthesis. Consistent with this hypothesis, deletion of the gene (devB) encoding the enzyme that catalyzes the next step in the oxidative PPP (6-phosphogluconolactonase) also resulted in increased antibiotic production. However, deletion of both zwf genes from the devB mutant resulted in reduced levels of ACT and RED production, suggesting that some of the NADPH made by the PPP is utilized, directly or indirectly, for antibiotic biosynthesis. Although applied here to the model antibiotics ACT and RED, such mutations may prove to be useful for improving the yield of commercially important secondary metabolites.
引用
收藏
页码:4731 / 4739
页数:9
相关论文
共 39 条
[1]   Solution of the structure of tetrameric human glucose 6-phosphate dehydrogenase by molecular replacement [J].
Au, SWN ;
Naylor, CE ;
Gover, S ;
Vandeputte-Rutten, L ;
Scopes, DA ;
Mason, PJ ;
Luzzatto, L ;
Lam, VMS ;
Adams, MJ .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 1999, 55 :826-834
[2]   PLASMID CLONING VECTORS FOR THE CONJUGAL TRANSFER OF DNA FROM ESCHERICHIA-COLI TO STREPTOMYCES SPP [J].
BIERMAN, M ;
LOGAN, R ;
OBRIEN, K ;
SENO, ET ;
RAO, RN ;
SCHONER, BE .
GENE, 1992, 116 (01) :43-49
[3]   High-yield actinorhodin production in fed-batch culture by a Streptomyces lividans strain overexpressing the pathway-specific activator gene actII-ORF4 [J].
Bruheim, P ;
Sletta, H ;
Bibb, MJ ;
White, J ;
Levine, DW .
JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY, 2002, 28 (02) :103-111
[4]   A theoretical analysis of the biosynthesis of actinorhodin in a hyper-producing Streptomyces lividans strain cultivated on various carbon sources [J].
Bruheim, P ;
Butler, M ;
Ellingsen, TE .
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2002, 58 (06) :735-742
[5]   Analysis of a ptsH homologue from Streptomyces coelicolor A3(2) [J].
Butler, MJ ;
Deutscher, J ;
Postma, PW ;
Wilson, TJG ;
Galinier, A ;
Bibb, MJ .
FEMS MICROBIOLOGY LETTERS, 1999, 177 (02) :279-288
[6]   Production of actinorhodin-related ''blue pigments'' by Streptomyces coelicolor A3(2) [J].
Bystrykh, LV ;
FernandezMoreno, MA ;
Herrema, JK ;
Malpartida, F ;
Hopwood, DA ;
Dijkhuizen, L .
JOURNAL OF BACTERIOLOGY, 1996, 178 (08) :2238-2244
[7]  
CHATER KF, 1990, BIO-TECHNOL, V8, P115, DOI 10.1038/nbt0290-115
[8]   Enhanced production of microbial metabolites in the presence of dimethyl sulfoxide [J].
Chen, GH ;
Wang, GYS ;
Li, X ;
Waters, B ;
Davies, J .
JOURNAL OF ANTIBIOTICS, 2000, 53 (10) :1145-1153
[9]   Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence [J].
Cole, ST ;
Brosch, R ;
Parkhill, J ;
Garnier, T ;
Churcher, C ;
Harris, D ;
Gordon, SV ;
Eiglmeier, K ;
Gas, S ;
Barry, CE ;
Tekaia, F ;
Badcock, K ;
Basham, D ;
Brown, D ;
Chillingworth, T ;
Connor, R ;
Davies, R ;
Devlin, K ;
Feltwell, T ;
Gentles, S ;
Hamlin, N ;
Holroyd, S ;
Hornby, T ;
Jagels, K ;
Krogh, A ;
McLean, J ;
Moule, S ;
Murphy, L ;
Oliver, K ;
Osborne, J ;
Quail, MA ;
Rajandream, MA ;
Rogers, J ;
Rutter, S ;
Seeger, K ;
Skelton, J ;
Squares, R ;
Squares, S ;
Sulston, JE ;
Taylor, K ;
Whitehead, S ;
Barrell, BG .
NATURE, 1998, 393 (6685) :537-+
[10]   Identification of the cDNA en coding human 6-phosphogluconolactonase, the enzyme catalyzing the second step of the pentose phosphate pathway [J].
Collard, F ;
Collet, JF ;
Gerin, I ;
Veiga-da-Cunha, M ;
Van Schaftingen, E .
FEBS LETTERS, 1999, 459 (02) :223-226